These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21440048)

  • 1. Operant-based instrumental learning for analysis of genetically modified models of Huntington's disease.
    Trueman RC; Dunnett SB; Brooks SP
    Brain Res Bull; 2012 Jun; 88(2-3):261-75. PubMed ID: 21440048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analyses of operant performance on the serial implicit learning task (SILT) in the YAC128 Huntington's disease mouse line.
    Brooks SP; Jones L; Dunnett SB
    Brain Res Bull; 2012 Jun; 88(2-3):130-6. PubMed ID: 21763407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Longitudinal Operant Assessment of Cognitive and Behavioural Changes in the HdhQ111 Mouse Model of Huntington's Disease.
    Yhnell E; Dunnett SB; Brooks SP
    PLoS One; 2016; 11(10):e0164072. PubMed ID: 27701442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of choice reaction time deficits in the Hdh(Q92) knock-in mouse model of Huntington's disease in the operant serial implicit learning task (SILT).
    Trueman RC; Brooks SP; Jones L; Dunnett SB
    Behav Brain Res; 2008 Jun; 189(2):317-24. PubMed ID: 18367261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five choice serial reaction time performance in the HdhQ92 mouse model of Huntington's disease.
    Trueman RC; Dunnett SB; Jones L; Brooks SP
    Brain Res Bull; 2012 Jun; 88(2-3):163-70. PubMed ID: 22085744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The operant serial implicit learning task reveals early onset motor learning deficits in the Hdh knock-in mouse model of Huntington's disease.
    Trueman RC; Brooks SP; Jones L; Dunnett SB
    Eur J Neurosci; 2007 Jan; 25(2):551-8. PubMed ID: 17284197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated Operant Assessments of Huntington's Disease Mouse Models.
    Yhnell E; Heuer A
    Methods Mol Biol; 2018; 1780():143-162. PubMed ID: 29856018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington's disease.
    Walker FO
    Lancet; 2007 Jan; 369(9557):218-28. PubMed ID: 17240289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utilisation of operant delayed matching and non-matching to position for probing cognitive flexibility and working memory in mouse models of Huntington's disease.
    Yhnell E; Dunnett SB; Brooks SP
    J Neurosci Methods; 2016 May; 265():72-80. PubMed ID: 26321735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive training modifies disease symptoms in a mouse model of Huntington's disease.
    Yhnell E; Lelos MJ; Dunnett SB; Brooks SP
    Exp Neurol; 2016 Aug; 282():19-26. PubMed ID: 27163546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis.
    Fusilli C; Migliore S; Mazza T; Consoli F; De Luca A; Barbagallo G; Ciammola A; Gatto EM; Cesarini M; Etcheverry JL; Parisi V; Al-Oraimi M; Al-Harrasi S; Al-Salmi Q; Marano M; Vonsattel JG; Sabatini U; Landwehrmeyer GB; Squitieri F
    Lancet Neurol; 2018 Nov; 17(11):986-993. PubMed ID: 30243861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disrupted temporal control in the R6/2 mouse model of Huntington's disease.
    Balci F; Day M; Rooney A; Brunner D
    Behav Neurosci; 2009 Dec; 123(6):1353-8. PubMed ID: 20001119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's disease.
    Fink KD; Rossignol J; Crane AT; Davis KK; Bavar AM; Dekorver NW; Lowrance SA; Reilly MP; Sandstrom MI; von Hörsten S; Lescaudron L; Dunbar GL
    Behav Neurosci; 2012 Jun; 126(3):479-87. PubMed ID: 22642889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice.
    Pang TYC; Stam NC; Nithianantharajah J; Howard ML; Hannan AJ
    Neuroscience; 2006 Aug; 141(2):569-584. PubMed ID: 16716524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanded CAG repeats in the murine Huntington's disease gene increases neuronal differentiation of embryonic and neural stem cells.
    Lorincz MT; Zawistowski VA
    Mol Cell Neurosci; 2009 Jan; 40(1):1-13. PubMed ID: 18625318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large genetic animal models of Huntington's Disease.
    Morton AJ; Howland DS
    J Huntingtons Dis; 2013; 2(1):3-19. PubMed ID: 25063426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a transgenic model of Huntington's disease in a non-human primate.
    Yang SH; Cheng PH; Banta H; Piotrowska-Nitsche K; Yang JJ; Cheng EC; Snyder B; Larkin K; Liu J; Orkin J; Fang ZH; Smith Y; Bachevalier J; Zola SM; Li SH; Li XJ; Chan AW
    Nature; 2008 Jun; 453(7197):921-4. PubMed ID: 18488016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtle but progressive cognitive deficits in the female tgHD hemizygote rat as demonstrated by operant SILT performance.
    Brooks S; Fielding S; Döbrössy M; von Hörsten S; Dunnett S
    Brain Res Bull; 2009 Jun; 79(5):310-5. PubMed ID: 19480990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and environmental factors in the pathogenesis of Huntington's disease.
    van Dellen A; Hannan AJ
    Neurogenetics; 2004 Feb; 5(1):9-17. PubMed ID: 14745585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.
    Wright GEB; Black HF; Collins JA; Gall-Duncan T; Caron NS; Pearson CE; Hayden MR
    Lancet Neurol; 2020 Nov; 19(11):930-939. PubMed ID: 33098802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.